TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Movement System Impairment Based Classification Versus General Exercise for Chronic Non-specific Low Back Pain: a Randomised Controlled Trial
Brief Summary: The objective of this study is to investigate the efficacy of a treatment based on Movement System Impairment based classification (MSI) model in patients with chronic non-specific low back pain.


Options:
A: Intervention Type: PROCEDURE; Name: Mod. functional restoration-Individ. dynamic back-muscle; Assigned to Arm(s): N/A
B: Arm Label: Core stabilization and psychosocial education; Type: EXPERIMENTAL; Interventions: Behavioral: Core stabilization and psychosocial education | Arm Label: Core stabilization exercise only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Core stabilization exercise only | Arm Label: Psychosocial education class only.; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychosocial education class only | Arm Label: Traditional Army training; Type: OTHER; Interventions: Behavioral: Traditional Army training | Intervention Type: BEHAVIORAL; Name: Traditional Army training; Assigned to Arm(s): Traditional Army training | Intervention Type: BEHAVIORAL; Name: Core stabilization exercise only; Assigned to Arm(s): Core stabilization exercise only | Intervention Type: BEHAVIORAL; Name: Psychosocial education class only; Assigned to Arm(s): Psychosocial education class only. | Intervention Type: BEHAVIORAL; Name: Core stabilization and psychosocial education; Assigned to Arm(s): Core stabilization and psychosocial education
C: Arm Label: Treatment based on Movement System Impairment based model; Type: EXPERIMENTAL; Interventions: Other: Treatment based on Movement System Impairment model | Arm Label: General exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: General exercise | Intervention Type: OTHER; Name: Treatment based on Movement System Impairment model; Assigned to Arm(s): Treatment based on Movement System Impairment based model | Intervention Type: OTHER; Name: General exercise; Assigned to Arm(s): General exercise
D: Arm Label: Graded Activity; Type: ACTIVE_COMPARATOR; Interventions: Other: Graded Activity, Other: Supervised Exercises | Arm Label: Supervised exercises; Type: ACTIVE_COMPARATOR; Interventions: Other: Graded Activity, Other: Supervised Exercises | Intervention Type: OTHER; Name: Graded Activity; Assigned to Arm(s): Graded Activity, Supervised exercises | Intervention Type: OTHER; Name: Supervised Exercises; Assigned to Arm(s): Graded Activity, Supervised exercises

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interdisciplinary Rehabilitation of Patients With Glioma During Anti-cancer Treatment
Brief Summary: The results of the present RCT study will add to the growing body of literature investigating the potential role of exercise as a supportive therapeutic intervention for patient with glioma.


Options:
A: Arm Label: Interdisciplinary rehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Interdisciplinary rehabilitation | Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Interdisciplinary rehabilitation; Assigned to Arm(s): Interdisciplinary rehabilitation
B: Arm Label: Connected device; Type: EXPERIMENTAL; Interventions: Device: Connected device | Arm Label: Therapeutic education; Type: EXPERIMENTAL; Interventions: Behavioral: Therapeutic education | Arm Label: Combined; Type: EXPERIMENTAL; Interventions: Device: Connected device, Behavioral: Therapeutic education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Connected device; Assigned to Arm(s): Combined, Connected device | Intervention Type: BEHAVIORAL; Name: Therapeutic education; Assigned to Arm(s): Combined, Therapeutic education
C: Arm Label: Experimetal Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored health partnership program | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: Behavioral: Usual care and health education workshop | Intervention Type: BEHAVIORAL; Name: Tailored health partnership program; Assigned to Arm(s): Experimetal Arm | Intervention Type: BEHAVIORAL; Name: Usual care and health education workshop; Assigned to Arm(s): Control Arm
D: Arm Label: gPCC-G (Gothenburg Person Centred Care) Group; Type: EXPERIMENTAL; Interventions: Other: gPCC (Gothenburg Person Centred Care) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: gPCC (Gothenburg Person Centred Care); Assigned to Arm(s): gPCC-G (Gothenburg Person Centred Care) Group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nueva Vida Intervention: Improving QOL in Latina Breast Cancer Survivors and Their Caregivers
Brief Summary: Latina breast cancer survivors report lower quality of life (QOL) than non-Latina survivors. Lower QOL can lead to poorer functional and cancer-related survival outcomes. The friends and family of Latina cancer patients are also impacted by a loved one's diagnosis of breast cancer. Through strong community-academic partnerships, the investigators seek to improve the QOL of Latina survivors and their caregivers with a culturally-relevant intervention. In this project, the investigators plan to further develop and refine the intervention and then test it through a randomized controlled trial. First, the investigators will conduct in-depth qualitative interviews with 10 survivor-caregiver dyads (pairs) to see if the intervention fits for survivors and caregivers in different parts of the country. Then, the investigators will revise the intervention. Finally, the investigators will test the intervention in a randomized controlled trial. The investigators will invite 125 survivor-caregiver dyads to be a part of our study. Half will be asked to complete the intervention and half will be offered the usual services, such as support groups. The information learned from this study could help improve the quality of life in Latina breast cancer survivors and their caregivers. Physicians, survivors, and community groups can also benefit from this study because they will have more information about the needs of Latina breast cancer survivors. The investigators hope to use the information to help other types of survivors and caregivers in the future.


Options:
A: Arm Label: initial survivorship planning consultation; Type: N/A; Interventions: N/A | Arm Label: initial wellness rehabilitation consultation; Type: N/A; Interventions: N/A
B: Arm Label: communication lecture; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: communication lecture | Arm Label: lecture plus CD-ROM; Type: EXPERIMENTAL; Interventions: Behavioral: lecture plus CD-ROM | Intervention Type: BEHAVIORAL; Name: communication lecture; Assigned to Arm(s): communication lecture | Intervention Type: BEHAVIORAL; Name: lecture plus CD-ROM; Assigned to Arm(s): lecture plus CD-ROM
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communication training and coaching | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Communication training and coaching; Assigned to Arm(s): Intervention
D: Arm Label: Nueva Vida Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Nueva Vida Intervention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Nueva Vida Intervention; Assigned to Arm(s): Nueva Vida Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nueva Vida Intervention: Improving QOL in Latina Breast Cancer Survivors and Their Caregivers
Brief Summary: Latina breast cancer survivors report lower quality of life (QOL) than non-Latina survivors. Lower QOL can lead to poorer functional and cancer-related survival outcomes. The friends and family of Latina cancer patients are also impacted by a loved one's diagnosis of breast cancer. Through strong community-academic partnerships, the investigators seek to improve the QOL of Latina survivors and their caregivers with a culturally-relevant intervention. In this project, the investigators plan to further develop and refine the intervention and then test it through a randomized controlled trial. First, the investigators will conduct in-depth qualitative interviews with 10 survivor-caregiver dyads (pairs) to see if the intervention fits for survivors and caregivers in different parts of the country. Then, the investigators will revise the intervention. Finally, the investigators will test the intervention in a randomized controlled trial. The investigators will invite 125 survivor-caregiver dyads to be a part of our study. Half will be asked to complete the intervention and half will be offered the usual services, such as support groups. The information learned from this study could help improve the quality of life in Latina breast cancer survivors and their caregivers. Physicians, survivors, and community groups can also benefit from this study because they will have more information about the needs of Latina breast cancer survivors. The investigators hope to use the information to help other types of survivors and caregivers in the future.


Options:
A: Arm Label: Brief; Type: EXPERIMENTAL; Interventions: Behavioral: Brief FOCUS Program | Arm Label: Extensive; Type: EXPERIMENTAL; Interventions: Behavioral: Extensive FOCUS Program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Brief FOCUS Program; Assigned to Arm(s): Brief | Intervention Type: BEHAVIORAL; Name: Extensive FOCUS Program; Assigned to Arm(s): Extensive
B: Arm Label: Psycho-educational support group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Psycho-educational support group therapy | Intervention Type: BEHAVIORAL; Name: Psycho-educational support group therapy; Assigned to Arm(s): Psycho-educational support group therapy
C: Arm Label: Nueva Vida Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Nueva Vida Intervention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Nueva Vida Intervention; Assigned to Arm(s): Nueva Vida Intervention
D: Arm Label: Experimental: supportive care; Type: EXPERIMENTAL; Interventions: Other: Supportive care | Arm Label: Control: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Supportive care; Assigned to Arm(s): Experimental: supportive care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 2, Uncontrolled, Three-Stage, Dose-Escalation Cohort Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Clinical Activity of OMS721 in Adults With Thrombotic Microangiopathies
Brief Summary: The purpose of this study is to assess the safety, efficacy, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of OMS721 in patients with thrombotic microangiopathies (TMA).


Options:
A: Arm Label: Ravulizumab; Type: EXPERIMENTAL; Interventions: Biological: Ravulizumab | Arm Label: Eculizumab; Type: ACTIVE_COMPARATOR; Interventions: Biological: Ravulizumab, Biological: Eculizumab | Intervention Type: BIOLOGICAL; Name: Ravulizumab; Assigned to Arm(s): Eculizumab, Ravulizumab | Intervention Type: BIOLOGICAL; Name: Eculizumab; Assigned to Arm(s): Eculizumab
B: Arm Label: ECULIZUMAB; Type: OTHER; Interventions: Drug: Eculizumab | Intervention Type: DRUG; Name: Eculizumab; Assigned to Arm(s): ECULIZUMAB
C: Arm Label: OMS721 low dose; Type: EXPERIMENTAL; Interventions: Biological: OMS721 | Arm Label: OMS721 medium dose; Type: EXPERIMENTAL; Interventions: Biological: OMS721 | Arm Label: OMS721 high dose; Type: EXPERIMENTAL; Interventions: Biological: OMS721 | Intervention Type: BIOLOGICAL; Name: OMS721; Assigned to Arm(s): OMS721 high dose, OMS721 low dose, OMS721 medium dose
D: Arm Label: Ravulizumab; Type: EXPERIMENTAL; Interventions: Biological: Ravulizumab | Intervention Type: BIOLOGICAL; Name: Ravulizumab; Assigned to Arm(s): Ravulizumab

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Reverse Innovation and Patient Engagement to Improve Quality of Care and Patient Outcomes
Brief Summary: Project CONNECT ("Community-based Organizations Neighborhood Network: Enhancing Capacity Together") is a randomized controlled trial that involves 22 community-based organizations (CBOs) located in Baltimore, MD. Half of these organizations were randomly assigned to the intervention group using a constrained cluster randomization process. The remaining 11 are a part of the control intervention group. The intervention is a co-developed set of IT tools hypothesized to improve the connections among intervention CBOs, Johns Hopkins health care facilities and CBO clients.


Options:
A: Arm Label: Intervention CBOs; Type: EXPERIMENTAL; Interventions: Other: Co-developed IT intervention | Arm Label: Control CBOs; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Co-developed IT intervention; Assigned to Arm(s): Intervention CBOs
B: Arm Label: EBQI-Supported WH-PACT Implementation; Type: EXPERIMENTAL; Interventions: Other: Multilevel stakeholder engagement, Other: Quality improvement (QI) education/training, Other: Technical support, Other: Formative feedback, Other: External practice facilitation, Other: National policy guidance | Arm Label: Routine WH-PACT Implementation; Type: ACTIVE_COMPARATOR; Interventions: Other: National policy guidance | Intervention Type: OTHER; Name: Multilevel stakeholder engagement; Assigned to Arm(s): EBQI-Supported WH-PACT Implementation | Intervention Type: OTHER; Name: Quality improvement (QI) education/training; Assigned to Arm(s): EBQI-Supported WH-PACT Implementation | Intervention Type: OTHER; Name: Technical support; Assigned to Arm(s): EBQI-Supported WH-PACT Implementation | Intervention Type: OTHER; Name: Formative feedback; Assigned to Arm(s): EBQI-Supported WH-PACT Implementation | Intervention Type: OTHER; Name: External practice facilitation; Assigned to Arm(s): EBQI-Supported WH-PACT Implementation | Intervention Type: OTHER; Name: National policy guidance; Assigned to Arm(s): EBQI-Supported WH-PACT Implementation, Routine WH-PACT Implementation
C: Arm Label: NU-HOME Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: NU-HOME Intervention | Arm Label: Delayed Intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: NU-HOME Intervention; Assigned to Arm(s): NU-HOME Intervention
D: Arm Label: All Nations Breath of Life (ANBL); Type: EXPERIMENTAL; Interventions: Behavioral: All Nations Breath of Life (ANBL), Drug: Pharmacotherapy | Arm Label: Nontailored (NT); Type: EXPERIMENTAL; Interventions: Behavioral: Nontailored program (NT), Drug: Pharmacotherapy | Intervention Type: BEHAVIORAL; Name: All Nations Breath of Life (ANBL); Assigned to Arm(s): All Nations Breath of Life (ANBL) | Intervention Type: BEHAVIORAL; Name: Nontailored program (NT); Assigned to Arm(s): Nontailored (NT) | Intervention Type: DRUG; Name: Pharmacotherapy; Assigned to Arm(s): All Nations Breath of Life (ANBL), Nontailored (NT)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective, Multi-center, Cluster-randomized, Pragmatic, Mixed-method Pilot Study Evaluating a Consultation Training Program for Physicians Within the Framework of KOKON (Competence Network Complementary Medicine in Oncology)
Brief Summary: The aim of the study is to investigate the effect of a consultation training program for physicians on the quality of their consultations of breast cancer patients regarding complementary medicine. We assume that the training program might enhance the communication of relevant information, empathy of the physicians or satisfaction with the consultation.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communication training and coaching | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Communication training and coaching; Assigned to Arm(s): Intervention
B: Arm Label: Consultation by a trained physician; Type: EXPERIMENTAL; Interventions: Behavioral: Consultation by a trained physician | Arm Label: Consultation by an untrained physician; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Consultation by an untrained physician | Intervention Type: BEHAVIORAL; Name: Consultation by a trained physician; Assigned to Arm(s): Consultation by a trained physician | Intervention Type: BEHAVIORAL; Name: Consultation by an untrained physician; Assigned to Arm(s): Consultation by an untrained physician
C: Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Behavioral: Communication skills training | Arm Label: Waiting-list group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Communication skills training; Assigned to Arm(s): Experimental group
D: Arm Label: Intervention Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Training Program Intervention | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training Program Intervention; Assigned to Arm(s): Intervention Arm

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving the Health of South African Women With Traumatic Stress in HIV Care
Brief Summary: In this study, the investigators propose to develop Improving AIDS Care after Trauma (ImpACT), an intervention based on theories of stress and coping and evidence-based treatment for traumatic stress. The intervention will target women in South Africa who have histories of sexual trauma and are newly initiating antiretroviral therapy (ART) in order to reduce avoidant coping and traumatic stress, improve care engagement, and reduce HIV risk behaviors.


Options:
A: Arm Label: Motivational Interviewing (MI); Type: EXPERIMENTAL; Interventions: Behavioral: Motivational interviewing (MI) | Intervention Type: BEHAVIORAL; Name: Motivational interviewing (MI); Assigned to Arm(s): Motivational Interviewing (MI)
B: Arm Label: Treamtent-as-usual; Type: OTHER; Interventions: Other: Treatment-as-usual | Arm Label: Narrative Exposure Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Narrative Exposure Therapy | Intervention Type: BEHAVIORAL; Name: Narrative Exposure Therapy; Assigned to Arm(s): Narrative Exposure Therapy | Intervention Type: OTHER; Name: Treatment-as-usual; Assigned to Arm(s): Treamtent-as-usual
C: Arm Label: CBT-E; Type: EXPERIMENTAL; Interventions: Behavioral: Specific Modules, Behavioral: Cognitive behavioral therapy | Arm Label: CBT-C; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive behavioral therapy | Intervention Type: BEHAVIORAL; Name: Specific Modules; Assigned to Arm(s): CBT-E | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy; Assigned to Arm(s): CBT-C, CBT-E
D: Arm Label: Mental health treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Improving AIDS Care after Trauma (ImpACT) | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Improving AIDS Care after Trauma (ImpACT); Assigned to Arm(s): Mental health treatment

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical Evaluation of Systemic Moxifloxacin Compared to Amoxicillin Plus Metronidazole Adjunct to Non-surgical Treatment in Generalized Aggressive Periodontitis: A Randomized Clinical Trial
Brief Summary: The objective of this randomized clinical study was to evaluate the effect of systemic administration of moxifloxacin compared to amoxicillin plus metronidazole combined with non-surgical treatment in patients with generalized aggressive periodontitis (GAgP) in 6-month follow-up.

A total of 40 systemically healthy patients with GAgP will evaluate in this randomized clinical trial. Periodontal parameters (plaque index, gingival index, probing depth, bleeding on probing, clinical attachment level) will be recorded at baseline, 1st, 3rd and 6th month. Patients will receive either 400 mg moxifloxacin per os once daily or 500 mg metronidazole and 500 mg amoxicillin per os three times daily for 7 days consecutively.


Options:
A: Arm Label: amoxicillin+metronidazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxicillin, Drug: Metronidazole | Arm Label: moxifloxacin; Type: EXPERIMENTAL; Interventions: Drug: Moxifloxacin | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): amoxicillin+metronidazole | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): amoxicillin+metronidazole | Intervention Type: DRUG; Name: Moxifloxacin; Assigned to Arm(s): moxifloxacin
B: Arm Label: Amoxicillin and Metronidazole; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Full-mouth ultrasonic debridement, Drug: Amoxicillin, Drug: Metronidazole | Arm Label: Clarithromycin; Type: EXPERIMENTAL; Interventions: Procedure: Full-mouth ultrasonic debridement, Drug: Clarithromycin | Intervention Type: PROCEDURE; Name: Full-mouth ultrasonic debridement; Assigned to Arm(s): Amoxicillin and Metronidazole, Clarithromycin | Intervention Type: DRUG; Name: Clarithromycin; Assigned to Arm(s): Clarithromycin | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): Amoxicillin and Metronidazole | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): Amoxicillin and Metronidazole
C: Arm Label: test; Type: EXPERIMENTAL; Interventions: Drug: Amoxicillin and Metronidazole | Arm Label: control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Amoxicillin and Metronidazole; Assigned to Arm(s): test | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): control
D: Arm Label: clarithromycin group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clarithromycin, Other: One-stage full-mouth ultrasonic debridement (FMUD) | Arm Label: placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Other: One-stage full-mouth ultrasonic debridement (FMUD) | Intervention Type: DRUG; Name: Clarithromycin; Assigned to Arm(s): clarithromycin group | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo group | Intervention Type: OTHER; Name: One-stage full-mouth ultrasonic debridement (FMUD); Assigned to Arm(s): clarithromycin group, placebo group

Answer: A